Filter
551
Text search:
gram
positive
Featured
Recommendations
74
New Publications
157
Language
Document type
No document type
296
Guidelines
122
Studies & Reports
86
Manuals
25
Strategic & Response Plan
8
Training Material
5
Situation Updates
3
Fact sheets
3
Brochures
2
Infographics
1
Countries / Regions
India
88
South Africa
25
Kenya
14
Nepal
12
Global
12
Tanzania
11
Nigeria
9
Philippines
9
Africa
9
Ethiopia
8
Sierra Leone
7
Congo, Democratic Republic of
7
Ghana
7
Zimbabwe
6
Rwanda
6
Malawi
6
Namibia
6
Bangladesh
5
Uganda
4
Ukraine
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Western and Central Europe
4
Indonesia
3
West and Central Africa
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Zambia
2
Syria
2
Thailand
2
Eswatini/ Swaziland
2
South–East Asia Region
2
Western Pacific Region
2
Turkmenistan
2
Burkina Faso
1
Mali
1
Saudi Arabia
1
Haiti
1
South Sudan
1
Jordan
1
Lebanon
1
Cambodia
1
Mozambique
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Argentina
1
Brazil
1
North Macedonia
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Yemen
1
Eastern Europe and Central Asia
1
Asia
1
Fiji
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Iran
1
Gabon
1
Denmark
1
France
1
Authors & Publishers
Publication Years
Category
Countries
240
Clinical Guidelines
85
Women & Child Health
35
Key Resources
21
Pharmacy & Technologies
19
Public Health
18
Capacity Building
6
Toolboxes
AMR
117
Rapid Response
28
HIV
22
Pharmacy
19
Mental Health
17
TB
17
COVID-19
17
Ebola
14
Caregiver
13
NTDs
11
NCDs
7
Planetary Health
6
Cholera
5
Conflict
5
Natural Hazards
5
Refugee
5
Global Health Education
4
Disability
3
Polio
1
Zika
1
Specific Hazards
1
Health Financing Toolbox
1
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and
...
Treatment Recommendations for Adult Inpatients
Prepared by NGOs: “Legalife-Ukraine”, “Insight”, “Positive Women”, and “Svitanok”
For the submission to the 66th CEDAW Session Geneva, Switzerland
13 February 2017 - 03 March 2017
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t
...
Le présent document expose des recommandations exhaustives de l’OMS sur les soins prénatals systématiques à l’intention des femmes enceintes et des adolescentes. Le but de ces recommandations est de compléter les directives de l’OMS existantes sur la prise en charge des complications spé
...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
En 2016, en ce début de l’ère des objectifs de développement durable (ODD), la morbidité et la mortalité évitables liées à la grossesse restent inacceptablement élevées. Bien que des progrès substantiels aient été enregistrés, les pays doivent consolider et faire progresser ces acqui
...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical
...
